Identifying CSF and blood immune biomarkers of disease progression and response to IL-2 therapy in individuals with new-onset ALS'.

Project: Research

Project Details

StatusActive
Effective start/end date1/09/202531/05/2028

Collaborative partners

Funding

  • MNDA Motor Neurone Disease Association: £301,606.49